Welcome to LookChem.com Sign In|Join Free

CAS

  • or

77943-39-6

Post Buying Request

77943-39-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

77943-39-6 Usage

Chemical Properties

white to light yellow crystal powde

Uses

Different sources of media describe the Uses of 77943-39-6 differently. You can refer to the following data:
1. (4R,5S)-4-Methyl-5-phenyloxazolidinone is used as effective chiral auxiliary for conjugate addition asymmetric synthesis of (-)-aplysillamide B.
2. Evan′s chiral auxiliary (4R,5S)-(+)-4-Methyl-5-phenyl-2-oxazolidinone reacts with carboxylic acids to produce corresponding acyl derivatives in the presence of a diisopropylcarbodiimide reagent. It can also employed in the preparation of N-sulfinyloxazolidinone reagent (chiral sulfinyl transfer reagent), which reacts with nucleophiles such as Grignard reagents, enolates, and metalated amides to produce the chiral sulfoxides, sulfinate esters, and sulfonamides.

Preparation

Different sources of media describe the Preparation of 77943-39-6 differently. You can refer to the following data:
1. To a solution of (1S,2R)-norephedrine (40 g, 0.26 mol) in toluene (400 mL) was added diethyl carbonate (37 mL, 0.32 mol). The mixture was heated to reflux (under Ar) while 40 mL of solvent was removed through the use of a Dean–Stark apparatus. The mixture was allowed to cool for 20 min, and then sodium methoxide (1 g) was added. Upon reheating, an EtOH/toluene azeotropic mixture was removed at 75–77 °C. After 3 h, the reaction was complete and the temperature of the mixture had increased to 125 °C. The mixture was left to stand at room temperature for 16 h, whereupon (4R,5S)-4-methyl-5-phenyloxazolidin-2-one (40.6 g) crystallized and could be collected. The solvent was removed from the filtrate in vacuo and the residue was redissolved in EtOAc (250 mL). This solution was washed with brine (50 mL) and a precipitate was removed by filtration. The solvent was then removed in vacuo and toluene (50 mL) was added to the residue. Removal of the toluene by distillation yielded oily crystals of the oxazolidinone, which were washed with Et2O to afford 4.5 g (total 45 g, 97%).
2. A mechanically stirred mixture of (1S,2R)-norephedrine 710 (151 g, 1.00 mol) ([α]589 =+ 33.4 (c= 7, water)), as the hydrochloride salt, diphenyl carbonate (236 g, 1.10 mol), and anhydrous potassium carbonate (152 g, 1.10 mol) was heated at 110 °C for 4–6 h. The resultant mixture was then cooled to <60 °C. Excess diphenyl carbonate was hydrolyzed by adding methanol (600 mL) and heating the mixture under reflux for 0.5 h. Sufficient water (400–600 mL) was then added to dissolve the potassium carbonate. Methanol was removed in vacuo. The product and phenol were extracted into dichloromethane (3 × 1 L). The combined extracts were washed with 2 m aqueous sodium hydroxide (3 × 1 L) to remove the phenol, 1 m aqueous hydrochloric acid (1 × 1 L), and brine, dried over anhydrous magnesium sulfate, and concentrated in vacuo to give 195 g (110% mass balance) of a light-yellow solid. Recrystallization from toluene (600 mL) afforded 145–165 g (82–93%) of oxazolidinone 711 as a white crystalline solid.

Check Digit Verification of cas no

The CAS Registry Mumber 77943-39-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,7,9,4 and 3 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 77943-39:
(7*7)+(6*7)+(5*9)+(4*4)+(3*3)+(2*3)+(1*9)=176
176 % 10 = 6
So 77943-39-6 is a valid CAS Registry Number.
InChI:InChI=1/C10H11NO2/c1-7-9(13-10(12)11-7)8-5-3-2-4-6-8/h2-7,9H,1H3,(H,11,12)/t7-,9-/m1/s1

77943-39-6 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (298891)  (4R,5S)-(+)-4-Methyl-5-phenyl-2-oxazolidinone  99%

  • 77943-39-6

  • 298891-5G

  • 2,654.73CNY

  • Detail

77943-39-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name (4R,5S)-(+)-4-Methyl-5-phenyl-2-oxazolidinone

1.2 Other means of identification

Product number -
Other names (4R,5S)-4-methyl-5-phenyl-1,3-oxazolidin-2-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:77943-39-6 SDS

77943-39-6Synthetic route

N,O-dimethylhydroxylamine*hydrochloride
6638-79-5

N,O-dimethylhydroxylamine*hydrochloride

(4R,5S)-3-((E)-(2R,3R)-3-Hydroxy-2,4-dimethyl-hept-4-enoyl)-4-methyl-5-phenyl-oxazolidin-2-one
779353-80-9

(4R,5S)-3-((E)-(2R,3R)-3-Hydroxy-2,4-dimethyl-hept-4-enoyl)-4-methyl-5-phenyl-oxazolidin-2-one

A

(E)-(2R,3R)-3-Hydroxy-2,4-dimethyl-hept-4-enoic acid methoxy-methyl-amide
541511-47-1

(E)-(2R,3R)-3-Hydroxy-2,4-dimethyl-hept-4-enoic acid methoxy-methyl-amide

B

4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

Conditions
ConditionsYield
Stage #1: N,O-dimethylhydroxylamine*hydrochloride With trimethylaluminum In tetrahydrofuran; toluene at 0 - 20℃;
Stage #2: (4R,5S)-3-((E)-(2R,3R)-3-Hydroxy-2,4-dimethyl-hept-4-enoyl)-4-methyl-5-phenyl-oxazolidin-2-one In tetrahydrofuran; toluene at 0℃; for 1h;
A 100%
B 272 mg
N,O-dimethylhydroxylamine*hydrochloride
6638-79-5

N,O-dimethylhydroxylamine*hydrochloride

mephenoxalone
70-07-5

mephenoxalone

4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

Conditions
ConditionsYield
With hydrogenchloride; AlMe3 In tetrahydrofuran; hexane; dichloromethane100%
With hydrogenchloride; AlMe3 In tetrahydrofuran; hexane; dichloromethane100%
With hydrogenchloride; AlMe3 In tetrahydrofuran; hexane; dichloromethane100%
carbon monoxide
201230-82-2

carbon monoxide

(1S,2R)-(+)-norphedrine
37577-28-9

(1S,2R)-(+)-norphedrine

4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

Conditions
ConditionsYield
With copper diacetate; air; palladium diacetate In toluene under 760 Torr; for 2h; Heating;99%
With sodium acetate; palladium diacetate In acetonitrile at 20℃; under 760 Torr; Electrolysis;86%
N,O-dimethylhydroxylamine*hydrochloride
6638-79-5

N,O-dimethylhydroxylamine*hydrochloride

(2'R,3'S,4'S,4R,5S)-3-[3'-hydroxy-5'-(4
132969-62-1

(2'R,3'S,4'S,4R,5S)-3-[3'-hydroxy-5'-(4"-methoxyphenyl)methoxy-2',4'-dimethylpentanoyl]-5-phenyl-4-methyl-2-oxazolidinone

A

4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

B

(2R,3S,4S)-3-hydroxy-5-(4-methoxybenzyloxy)-2,4-dimethylpentanoic acid methoxymethylamide
252342-49-7

(2R,3S,4S)-3-hydroxy-5-(4-methoxybenzyloxy)-2,4-dimethylpentanoic acid methoxymethylamide

Conditions
ConditionsYield
Stage #1: N,O-dimethylhydroxylamine*hydrochloride With trimethylaluminum In tetrahydrofuran; hexane at 0 - 20℃; Metallation;
Stage #2: (2'R,3'S,4'S,4R,5S)-3-[3'-hydroxy-5'-(4"-methoxyphenyl)methoxy-2',4'-dimethylpentanoyl]-5-phenyl-4-methyl-2-oxazolidinone In tetrahydrofuran; hexane at -20℃; for 2.5h; Substitution; Further stages.;
A 80%
B 98%
carbon dioxide
124-38-9

carbon dioxide

(1S,2R)-(+)-norphedrine
37577-28-9

(1S,2R)-(+)-norphedrine

4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

Conditions
ConditionsYield
With triethylamine; acetyl chloride In acetonitrile at -40 - 25℃;97%
Stage #1: carbon dioxide; (1S,2R)-(+)-norphedrine With 1,8-diazabicyclo[5.4.0]undec-7-ene In acetonitrile at 20℃; for 0.75h;
Stage #2: With tributylphosphine; di-tert-butyl-diazodicarboxylate In acetonitrile at 0℃; for 0.333333h; Mitsunobu reaction;
84%
With tetramethylphenylguanidine; chlorophosphoric acid diphenyl ester In acetonitrile at -40 - 20℃;82%
Stage #1: carbon dioxide; (1S,2R)-(+)-norphedrine With N(Et)4(1+)*(2-pyrrolidone-anion) In acetonitrile at 20℃; for 1h; Carboxylation;
Stage #2: With p-toluenesulfonyl chloride In acetonitrile at 20℃; Cyclization; Further stages.;
79%
(4R,5S)-(+)-(5-benzyloxy-2-fluoro-3-(E)-pentenoyl)-4-methyl-5-phenyl-2-oxazolidinone
179927-67-4

(4R,5S)-(+)-(5-benzyloxy-2-fluoro-3-(E)-pentenoyl)-4-methyl-5-phenyl-2-oxazolidinone

A

4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

B

5-O-benzyl-2-deoxy-2-fluoro-L-γ-xylonic lactone
179927-65-2

5-O-benzyl-2-deoxy-2-fluoro-L-γ-xylonic lactone

C

5-O-benzyl-2-deoxy-2-fluoro-D-γ-xylonic lactone
179927-64-1

5-O-benzyl-2-deoxy-2-fluoro-D-γ-xylonic lactone

Conditions
ConditionsYield
With osmium(VIII) oxide; trimethylamine-N-oxide In water; acetone; tert-butyl alcohol at 20℃; for 2h; Oxidation; cyclization;A n/a
B 94%
C 86%
bis(phenyl) carbonate
102-09-0

bis(phenyl) carbonate

Acutrim
40626-29-7

Acutrim

4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

Conditions
ConditionsYield
With potassium carbonate at 110℃; for 6h;93%
Stage #1: bis(phenyl) carbonate; Acutrim With potassium carbonate at 100℃; for 6h;
Stage #2: In methanol for 0.5h; Heating;
C37H45NO6
954106-23-1

C37H45NO6

A

C27H36O5
954106-40-2

C27H36O5

B

4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

Conditions
ConditionsYield
With lithium hydroxide; dihydrogen peroxide In tetrahydrofuran at 20℃; for 2h;A 92%
B 79%
(4R,5S)-3-[(Z)-(R)-2-(tert-Butyl-diphenyl-silanyloxy)-dec-4-enoyl]-4-methyl-5-phenyl-oxazolidin-2-one
128891-59-8

(4R,5S)-3-[(Z)-(R)-2-(tert-Butyl-diphenyl-silanyloxy)-dec-4-enoyl]-4-methyl-5-phenyl-oxazolidin-2-one

A

4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

B

(2R,4Z)-2(tert-Butyldiphenylsiloxy)-4-decen-1-ol
126617-76-3

(2R,4Z)-2(tert-Butyldiphenylsiloxy)-4-decen-1-ol

Conditions
ConditionsYield
With lithium borohydride; water In tetrahydrofuran; diethyl ether Product distribution; Ambient temperature; other reducing reagents; var. N-acyloxazolidinones;A n/a
B 90%
(4R,5S)-3-((R)-2-Benzyl-4-methyl-pent-3-enoyl)-4-methyl-5-phenyl-oxazolidin-2-one
109687-75-4

(4R,5S)-3-((R)-2-Benzyl-4-methyl-pent-3-enoyl)-4-methyl-5-phenyl-oxazolidin-2-one

A

4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

B

4-methyl-2(R)-(phenylmethyl)-3-penten-1-ol
109687-76-5

4-methyl-2(R)-(phenylmethyl)-3-penten-1-ol

Conditions
ConditionsYield
With lithium aluminium tetrahydride In tetrahydrofuran at -78 - 0℃; for 1.5h;A 70%
B 90%
(2'S,4R,5S)-3-(2'-methyl-3'-phenylpropionyl)-4-methyl-5-phenyloxazolidin-2-one
80697-94-5

(2'S,4R,5S)-3-(2'-methyl-3'-phenylpropionyl)-4-methyl-5-phenyloxazolidin-2-one

A

4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

B

(S)-2-methyl-3-phenylpropan-1-ol
7384-80-7, 77943-96-5, 78964-61-1, 22436-06-2

(S)-2-methyl-3-phenylpropan-1-ol

Conditions
ConditionsYield
With Cp*RuCl{(C6H5)2P-(CH2)2NH2-κ2-P,N}; potassium tert-butylate; hydrogen In isopropyl alcohol at 80℃; under 22502.3 Torr; for 20h; Autoclave; optical yield given as %ee;A 89%
B 90%
(4R,5S)-3-[(2S)-2-{(2S)-N-benzyloxycarbonylpyrrolidin-2-yl}propanoyl]-4-methyl-5-phenyl-2-oxazolidinone
321851-63-2

(4R,5S)-3-[(2S)-2-{(2S)-N-benzyloxycarbonylpyrrolidin-2-yl}propanoyl]-4-methyl-5-phenyl-2-oxazolidinone

A

4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

B

(2S)-2-[(2S)-1-benzyloxycarbonylpyrrolidin-2-yl]-1-propanol
235084-93-2

(2S)-2-[(2S)-1-benzyloxycarbonylpyrrolidin-2-yl]-1-propanol

Conditions
ConditionsYield
With sodium tetrahydroborate In tetrahydrofuran; water at 5℃; for 15h;A 97 mg
B 88%
(4R,5S,2'R,3'R,2
133645-51-9

(4R,5S,2'R,3'R,2"S)-3-[3'-(N-tert-butoxycarbonyl-2"-pyrrolidinyl)-3"-hydroxy-2'-methylpropanoyl]-4-methyl-5-phenyl-2-oxazolidinone

A

4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

B

<1R-(1α,2β,7aα)>-Hexahydro-1-hydroxy-2-methyl-3-oxo-1H-pyrrolizine
133565-40-9

<1R-(1α,2β,7aα)>-Hexahydro-1-hydroxy-2-methyl-3-oxo-1H-pyrrolizine

Conditions
ConditionsYield
Stage #1: (4R,5S,2'R,3'R,2"S)-3-[3'-(N-tert-butoxycarbonyl-2"-pyrrolidinyl)-3"-hydroxy-2'-methylpropanoyl]-4-methyl-5-phenyl-2-oxazolidinone With trifluoroacetic acid at 20℃; for 0.333333h;
Stage #2: With potassium carbonate In ethanol; water at 0℃; for 1.5h;
A n/a
B 86%
(4R,5S)-3-<(2S)-1-oxo-2,4-dimethylpent-4-enyl>-4-methyl-5-phenyloxazolidin-2-one
80719-70-6

(4R,5S)-3-<(2S)-1-oxo-2,4-dimethylpent-4-enyl>-4-methyl-5-phenyloxazolidin-2-one

A

4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

B

(S)-(-)-2,4-dimethylpent-4-en-1-ol
82507-47-9

(S)-(-)-2,4-dimethylpent-4-en-1-ol

Conditions
ConditionsYield
With lithium aluminium tetrahydride In diethyl ether at 0℃; for 0.0833333h;A n/a
B 85%
(1S,2R)-(+)-norphedrine
37577-28-9

(1S,2R)-(+)-norphedrine

tetraethylammonium peroxycarbonate

tetraethylammonium peroxycarbonate

4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

Conditions
ConditionsYield
Stage #1: (1S,2R)-(+)-norphedrine; tetraethylammonium peroxycarbonate In acetonitrile at 20℃; for 2h; Acylation;
Stage #2: With p-toluenesulfonyl chloride In acetonitrile at 25℃; for 10h; Cyclization;
85%
carbon dioxide
124-38-9

carbon dioxide

(1S,2R)-(+)-norphedrine
37577-28-9

(1S,2R)-(+)-norphedrine

p-toluenesulfonyl chloride
98-59-9

p-toluenesulfonyl chloride

A

4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

B

N-[(1R,2S)-2-hydroxy-1-methyl-2-phenylethyl]-4-methylbenzenesulfonamide
58107-41-8, 58107-43-0, 108591-33-9, 131142-88-6, 143957-01-1, 136173-99-4

N-[(1R,2S)-2-hydroxy-1-methyl-2-phenylethyl]-4-methylbenzenesulfonamide

Conditions
ConditionsYield
Stage #1: (1S,2R)-(+)-norphedrine In acetonitrile at 20℃; Electrolysis;
Stage #2: carbon dioxide for 1h;
Stage #3: p-toluenesulfonyl chloride at 20℃;
A 85%
B 14%
(1S,2R)-(+)-norphedrine
37577-28-9

(1S,2R)-(+)-norphedrine

Diethyl carbonate
105-58-8

Diethyl carbonate

4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

Conditions
ConditionsYield
With potassium carbonate In toluene at 110℃; Inert atmosphere; Large scale reaction;84.3%
With potassium carbonate at 150℃; for 2.5h;83%
MCM-41-TBD; 1,3,4,6,7,8-hexahydro-2H-pyrimido[1,2-a]pyrimidine for 24h; Heating;59%
(4R,5S)-3-<(2R)-1-oxo-2-<<(phenylmethyl)thio>methyl>-3-phenylpropyl>-4-methyl-5-phenyl-2-oxazolidinone
95798-32-6

(4R,5S)-3-<(2R)-1-oxo-2-<<(phenylmethyl)thio>methyl>-3-phenylpropyl>-4-methyl-5-phenyl-2-oxazolidinone

A

4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

B

(2R)-2-<<(phenylmethyl)thio>methyl>-3-phenylpropanoic acid benzyl ester
95841-15-9

(2R)-2-<<(phenylmethyl)thio>methyl>-3-phenylpropanoic acid benzyl ester

Conditions
ConditionsYield
With lithium benzyloxide In tetrahydrofuran; hexane at 0℃; for 1.5h;A 75%
B 83%
C21H29NO3
954106-16-2

C21H29NO3

A

(2R,3S)-2,3,7-trimethyl-6-octen-1-ol
179913-85-0

(2R,3S)-2,3,7-trimethyl-6-octen-1-ol

B

4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

Conditions
ConditionsYield
With sodium tetrahydroborate In tetrahydrofuran; water at 20℃; for 5h;A 81%
B 83%
C17H23NO3

C17H23NO3

ethyl potassium malonate
6148-64-7

ethyl potassium malonate

A

4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

B

ethyl (R)-5-methyl-3-oxo-octanoate
874208-98-7

ethyl (R)-5-methyl-3-oxo-octanoate

Conditions
ConditionsYield
Stage #1: C17H23NO3; ethyl potassium malonate With triethylamine; magnesium chloride In acetonitrile at 80℃; for 20h;
Stage #2: With hydrogenchloride In water at 10℃; Further stages.;
A n/a
B 83%
(4R,5S)-4-methyl-3-((S)-2-methylpent-4-enoyl)-5-phenyloxazolidin-2-one
80697-95-6

(4R,5S)-4-methyl-3-((S)-2-methylpent-4-enoyl)-5-phenyloxazolidin-2-one

A

4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

B

(S)-(-)-2-methyl-4-penten-1-ol
5673-98-3, 63501-27-9, 88080-30-2, 63501-26-8

(S)-(-)-2-methyl-4-penten-1-ol

Conditions
ConditionsYield
With lithium aluminium tetrahydride In tetrahydrofuran -70 deg C, 40 min; -78 deg C, 1 h; -78 to -20 deg C, 2 h;A n/a
B 82%
(1S,2S)-2-amino-1-phenylpropanol
492-39-7

(1S,2S)-2-amino-1-phenylpropanol

Diethyl carbonate
105-58-8

Diethyl carbonate

4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

Conditions
ConditionsYield
With potassium carbonate In toluene at 130℃; Heating;80%
N,O-dimethylhydroxylamine*hydrochloride
6638-79-5

N,O-dimethylhydroxylamine*hydrochloride

(2'R,3'S,4R,5S)-3-(3'-hydroxy-2'-methyl-4'-phenylbutanoyl)-4-methyl-5-phenyloxazolidin-2-one
134440-87-2

(2'R,3'S,4R,5S)-3-(3'-hydroxy-2'-methyl-4'-phenylbutanoyl)-4-methyl-5-phenyloxazolidin-2-one

A

4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

B

(2R,3S)-3-hydroxy-2-methyl-4-phenylbutan-(N-methyl-O-methyl)-hydroxamide
184354-37-8

(2R,3S)-3-hydroxy-2-methyl-4-phenylbutan-(N-methyl-O-methyl)-hydroxamide

Conditions
ConditionsYield
With trimethylaluminum In dichloromethane at 0 - 4℃; for 3h;A n/a
B 78%
(4R,5S)-(+)-3-[(2R)-2-isopropyl-5-methyl-1-oxohex-5-en-1-yl]-4-methyl-5-phenyl-2-oxazolidinone
317801-57-3

(4R,5S)-(+)-3-[(2R)-2-isopropyl-5-methyl-1-oxohex-5-en-1-yl]-4-methyl-5-phenyl-2-oxazolidinone

A

4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

B

(R)-(+)-2-isopropyl-5-methylhex-5-ene-1-carboxylic acid
317801-61-9

(R)-(+)-2-isopropyl-5-methylhex-5-ene-1-carboxylic acid

Conditions
ConditionsYield
With lithium hydroxide; dihydrogen peroxide In tetrahydrofuran; water at 20℃; for 16h; cleavage;A n/a
B 75%
carbon dioxide
124-38-9

carbon dioxide

(1S,2R)-(+)-norphedrine
37577-28-9

(1S,2R)-(+)-norphedrine

diethyl chlorophosphate
814-49-3

diethyl chlorophosphate

A

4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

B

diethyl ((1S,2R)-1-hydroxy-1-phenylpropan-2-yl)phosphoramidate

diethyl ((1S,2R)-1-hydroxy-1-phenylpropan-2-yl)phosphoramidate

Conditions
ConditionsYield
With tetramethylphenylguanidine In acetonitrile at -40 - 20℃;A 55%
B n/a
With N,N,N',N'-tetramethyl-N-phenylguanidine In acetonitrile at -40 - 25℃;A 55%
B 22%
benzyl N-(1H-benzotriazol-1-ylmethyl)carbamate
125453-11-4

benzyl N-(1H-benzotriazol-1-ylmethyl)carbamate

(4R,5S)-4-methyl-5-phenyl-3-phenylacetyl-oxazolidin-2-one
96930-16-4

(4R,5S)-4-methyl-5-phenyl-3-phenylacetyl-oxazolidin-2-one

A

4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

B

[(S)-3-((4R,5S)-4-Methyl-2-oxo-5-phenyl-oxazolidin-3-yl)-3-oxo-2-phenyl-propyl]-carbamic acid benzyl ester

[(S)-3-((4R,5S)-4-Methyl-2-oxo-5-phenyl-oxazolidin-3-yl)-3-oxo-2-phenyl-propyl]-carbamic acid benzyl ester

C

[(R)-3-((4R,5S)-4-Methyl-2-oxo-5-phenyl-oxazolidin-3-yl)-3-oxo-2-phenyl-propyl]-carbamic acid benzyl ester

[(R)-3-((4R,5S)-4-Methyl-2-oxo-5-phenyl-oxazolidin-3-yl)-3-oxo-2-phenyl-propyl]-carbamic acid benzyl ester

Conditions
ConditionsYield
With lithium diisopropyl amide In tetrahydrofuranA 20%
B 54%
C 2%
(4R,5S)-4-methyl-5-phenyl-3-phenylacetyl-oxazolidin-2-one
96930-16-4

(4R,5S)-4-methyl-5-phenyl-3-phenylacetyl-oxazolidin-2-one

A

4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

B

[(S)-3-((4R,5S)-4-Methyl-2-oxo-5-phenyl-oxazolidin-3-yl)-3-oxo-2-phenyl-propyl]-carbamic acid benzyl ester

[(S)-3-((4R,5S)-4-Methyl-2-oxo-5-phenyl-oxazolidin-3-yl)-3-oxo-2-phenyl-propyl]-carbamic acid benzyl ester

C

[(R)-3-((4R,5S)-4-Methyl-2-oxo-5-phenyl-oxazolidin-3-yl)-3-oxo-2-phenyl-propyl]-carbamic acid benzyl ester

[(R)-3-((4R,5S)-4-Methyl-2-oxo-5-phenyl-oxazolidin-3-yl)-3-oxo-2-phenyl-propyl]-carbamic acid benzyl ester

Conditions
ConditionsYield
With benzyl N-(1H-benzotriazol-1-ylmethyl)carbamate; lithium diisopropyl amide In tetrahydrofuranA 20%
B 54%
C 2%
Acetic acid (1S,2R)-1-ethyl-2-methyl-3-((4R,5S)-4-methyl-2-oxo-5-phenyl-oxazolidin-3-yl)-3-oxo-propyl ester
142719-20-8

Acetic acid (1S,2R)-1-ethyl-2-methyl-3-((4R,5S)-4-methyl-2-oxo-5-phenyl-oxazolidin-3-yl)-3-oxo-propyl ester

A

4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

B

(2S,3R,6R,7S)-7-Ethyl-3,6-dimethyl-2-phenyl-1,8-dioxa-4-aza-cycloundecane-5,9,11-trione
142719-21-9

(2S,3R,6R,7S)-7-Ethyl-3,6-dimethyl-2-phenyl-1,8-dioxa-4-aza-cycloundecane-5,9,11-trione

C

(5R,6S)-6-Ethyl-4-hydroxy-5-methyl-5,6-dihydro-pyran-2-one
142761-27-1

(5R,6S)-6-Ethyl-4-hydroxy-5-methyl-5,6-dihydro-pyran-2-one

Conditions
ConditionsYield
With lithium hexamethyldisilazane In tetrahydrofuran at -78℃; for 2h;A 45%
B 43%
C 37%
ammonium thiocyanate
1147550-11-5

ammonium thiocyanate

Acutrim
40626-29-7

Acutrim

A

4-methyl-5-phenyl-thiazolidin-2-one

4-methyl-5-phenyl-thiazolidin-2-one

B

(4R,5R)-(+)-4-methyl-5-phenyl-thiazolidin-2-one

(4R,5R)-(+)-4-methyl-5-phenyl-thiazolidin-2-one

C

(4R,5S)-4-Methyl-5-phenyl-thiazolidine-2-thione

(4R,5S)-4-Methyl-5-phenyl-thiazolidine-2-thione

D

4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

Conditions
ConditionsYield
at 180 - 200℃; for 4h; Further byproducts given;A n/a
B 40%
C n/a
D n/a
(4R,5S)-(+)-3-[(2R)-2-isopropyl-5-methyl-1-oxohex-5-en-1-yl]-4-methyl-5-phenyl-2-oxazolidinone
317801-57-3

(4R,5S)-(+)-3-[(2R)-2-isopropyl-5-methyl-1-oxohex-5-en-1-yl]-4-methyl-5-phenyl-2-oxazolidinone

A

4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

B

(R)-(+)-2-isopropyl-5-methylhex-5-en-1-ol
264258-71-1

(R)-(+)-2-isopropyl-5-methylhex-5-en-1-ol

C

(2R)-N-2-((1S,2R)-2-methyl-1-phenylethoxy)-5-methyl-2-(1-methylethyl)-5-hexenyl amide

(2R)-N-2-((1S,2R)-2-methyl-1-phenylethoxy)-5-methyl-2-(1-methylethyl)-5-hexenyl amide

Conditions
ConditionsYield
With lithium aluminium tetrahydride In tetrahydrofuran at -78 - 0℃; Reduction;A 25%
B 33%
C 39%
4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

(R)-6-cyclohexyl-4-methylhexanoic acid
849488-05-7

(R)-6-cyclohexyl-4-methylhexanoic acid

(4R,5S)-3-((R)-6-cyclohexyl-4-methyl-hexanoyl)-4-methyl-5-phenyl-oxazolidin-2-one

(4R,5S)-3-((R)-6-cyclohexyl-4-methyl-hexanoyl)-4-methyl-5-phenyl-oxazolidin-2-one

Conditions
ConditionsYield
Stage #1: (R)-6-cyclohexyl-4-methylhexanoic acid With pivaloyl chloride; triethylamine In tetrahydrofuran at 0℃; for 1h;
Stage #2: 4-methyl-5-phenyloxazolidin-2-one With lithium chloride In tetrahydrofuran at 0 - 20℃;
100%
4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

pent-4-enoyl chloride
39716-58-0

pent-4-enoyl chloride

(4R,5S)-4-methyl-3-pent-4-enoyl-5-phenyloxazolidin-2-one
96930-18-6

(4R,5S)-4-methyl-3-pent-4-enoyl-5-phenyloxazolidin-2-one

Conditions
ConditionsYield
Stage #1: 4-methyl-5-phenyloxazolidin-2-one With n-butyllithium In tetrahydrofuran; hexane at -78℃; Inert atmosphere;
Stage #2: pent-4-enoyl chloride In tetrahydrofuran; hexane at -78 - 20℃; for 2h; Inert atmosphere;
99%
Stage #1: 4-methyl-5-phenyloxazolidin-2-one With n-butyllithium In tetrahydrofuran; hexane at -78℃; Inert atmosphere;
Stage #2: pent-4-enoyl chloride In tetrahydrofuran; hexane at 0 - 20℃; for 0.5h; Inert atmosphere;
99%
Stage #1: 4-methyl-5-phenyloxazolidin-2-one With n-butyllithium In tetrahydrofuran; hexane at -78℃; for 0.583333h;
Stage #2: pent-4-enoyl chloride In tetrahydrofuran; hexane at -78 - -20℃; Further stages.;
86%
With n-butyllithium 1.) THF, -78 deg C, 1 h, 2.) 20 deg C, 24 h; Yield given. Multistep reaction;
4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

(Z)-Dec-4-enoyl chloride
57679-86-4, 70173-09-0

(Z)-Dec-4-enoyl chloride

(4R,5S)-3-((Z)-Dec-4-enoyl)-4-methyl-5-phenyl-oxazolidin-2-one
118267-98-4

(4R,5S)-3-((Z)-Dec-4-enoyl)-4-methyl-5-phenyl-oxazolidin-2-one

Conditions
ConditionsYield
With n-butyllithium In tetrahydrofuran at -78 - -10℃;99%
4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

acetyl chloride
75-36-5

acetyl chloride

(4R,5S)-3-acetyl-4-methyl-5-phenyl-2-oxazolidinone
96093-41-3

(4R,5S)-3-acetyl-4-methyl-5-phenyl-2-oxazolidinone

Conditions
ConditionsYield
With n-butyllithium In tetrahydrofuran at 0℃;99%
With n-butyllithium In tetrahydrofuran 1.) -78 deg C, 20 min, 2.) r.t., 20 min;90%
4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

butyryl chloride
141-75-3

butyryl chloride

(4R,5S)-(+)-4-methyl-3-(1'-oxobutyl)-5-phenyloxazolidin-2-one
80697-91-2

(4R,5S)-(+)-4-methyl-3-(1'-oxobutyl)-5-phenyloxazolidin-2-one

Conditions
ConditionsYield
Stage #1: 4-methyl-5-phenyloxazolidin-2-one With n-butyllithium In tetrahydrofuran; hexane
Stage #2: butyryl chloride In tetrahydrofuran; hexane at 20℃; for 2h;
99%
With n-butyllithium In tetrahydrofuran at -78℃;91%
With n-butyllithium 1.) THF, -78 deg C, 1 h, 2.) 20 deg C, 24 h; Yield given. Multistep reaction;
4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

isopentanoyl chloride
108-12-3

isopentanoyl chloride

(4R,5S)-(+)-3-[3-methyl-1-oxobut-1-yl]-4-methyl-5-phenyl-2-oxazolidinone
107599-99-5

(4R,5S)-(+)-3-[3-methyl-1-oxobut-1-yl]-4-methyl-5-phenyl-2-oxazolidinone

Conditions
ConditionsYield
Stage #1: 4-methyl-5-phenyloxazolidin-2-one With n-butyllithium In tetrahydrofuran; hexane
Stage #2: isopentanoyl chloride In tetrahydrofuran; hexane at 20℃; for 2h;
99%
Stage #1: 4-methyl-5-phenyloxazolidin-2-one With n-butyllithium In tetrahydrofuran at -78℃; Inert atmosphere;
Stage #2: isopentanoyl chloride In tetrahydrofuran at 20℃; for 2h; Inert atmosphere;
99%
Stage #1: 4-methyl-5-phenyloxazolidin-2-one With n-butyllithium In tetrahydrofuran; hexane at -78℃; for 0.166667h;
Stage #2: isopentanoyl chloride In tetrahydrofuran; hexachloroethane at -78℃; for 0.5h;
39%
With n-butyllithium 1.) THF, hexane, -78 deg C, 5 min, 2.) THF, hexane, from -78 deg C to RT, 30 min; Yield given. Multistep reaction;
With n-butyllithium In tetrahydrofuran at -78 - 20℃;
4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

1-iodo-2,2-dimethyl-1,2-propadiene
31819-97-3

1-iodo-2,2-dimethyl-1,2-propadiene

(4R,5S)-4-Methyl-3-(3-methyl-buta-1,2-dienyl)-5-phenyl-oxazolidin-2-one

(4R,5S)-4-Methyl-3-(3-methyl-buta-1,2-dienyl)-5-phenyl-oxazolidin-2-one

Conditions
ConditionsYield
With potassium phosphate; copper(I) thiophene-2-carboxylate; (1S,2S)-N,N'-dimethyl-1,2-diaminocyclohexane In toluene at 85℃; for 5h;99%
4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

cyclopentanepropanoyl chloride
104-97-2

cyclopentanepropanoyl chloride

(4R,5S)-3-(3-cyclopentylpropanoyl)-4-methyl-5-phenyloxazolidin-2-one
944385-34-6

(4R,5S)-3-(3-cyclopentylpropanoyl)-4-methyl-5-phenyloxazolidin-2-one

Conditions
ConditionsYield
With n-butyllithium In tetrahydrofuran; hexane at -78 - 20℃; for 1.5h;99%
4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

propionyl chloride
79-03-8

propionyl chloride

(4R,5S)-4-methyl-5-phenyl-3-propionyloxazolidin-2-one
77877-20-4

(4R,5S)-4-methyl-5-phenyl-3-propionyloxazolidin-2-one

Conditions
ConditionsYield
With n-butyllithium In tetrahydrofuran; hexane at -78 - 20℃;98%
Stage #1: 4-methyl-5-phenyloxazolidin-2-one With n-butyllithium In tetrahydrofuran; hexane
Stage #2: propionyl chloride In tetrahydrofuran; hexane at 20℃; for 2h;
98%
Stage #1: 4-methyl-5-phenyloxazolidin-2-one With n-butyllithium In tetrahydrofuran; hexane at -78℃; for 1h; Inert atmosphere;
Stage #2: propionyl chloride In tetrahydrofuran; hexane at -78 - -50℃; for 2h;
98%
4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

isobutyryl chloride
79-30-1

isobutyryl chloride

(4R,5S)-3-isobutyryl-4-methyl-5-phenyloxazolidin-2-one

(4R,5S)-3-isobutyryl-4-methyl-5-phenyloxazolidin-2-one

Conditions
ConditionsYield
Stage #1: 4-methyl-5-phenyloxazolidin-2-one With n-butyllithium In tetrahydrofuran at -78℃; for 0.75h; deprotonation;
Stage #2: isobutyryl chloride In tetrahydrofuran at -78℃; for 2h; Acylation;
98%
4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

Hexanoyl chloride
142-61-0

Hexanoyl chloride

(4R,5S)-3-hexanoyl-4-methyl-5-phenyloxazolidin-2-one
131636-15-2

(4R,5S)-3-hexanoyl-4-methyl-5-phenyloxazolidin-2-one

Conditions
ConditionsYield
With n-butyllithium In tetrahydrofuran at -78℃;97%
Stage #1: 4-methyl-5-phenyloxazolidin-2-one With n-butyllithium In tetrahydrofuran; hexane at -78℃; for 0.166667h;
Stage #2: Hexanoyl chloride In tetrahydrofuran; hexane at -78℃; for 0.5h;
Stage #3: With sodium hydroxide In tetrahydrofuran; hexane; water
72%
Stage #1: 4-methyl-5-phenyloxazolidin-2-one With n-butyllithium In tetrahydrofuran; hexane; ethyl acetate at -78℃; for 0.166667h;
Stage #2: Hexanoyl chloride In tetrahydrofuran; hexane at -78 - 20℃;
72%
4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

propionic acid anhydride
123-62-6

propionic acid anhydride

(4R,5S)-4-methyl-5-phenyl-3-propionyloxazolidin-2-one
77877-20-4

(4R,5S)-4-methyl-5-phenyl-3-propionyloxazolidin-2-one

Conditions
ConditionsYield
With electrogenerated base from 2-pyrrolidone; tetraethylammonium perchlorate In acetonitrile at 20℃;97%
With dmap; triethylamine In tetrahydrofuran for 1h; Ambient temperature;73%
With 2-phenyl-3,4-dihydro-2H-benzo[4,5]thiazolo[3,2-a]pyrimidine; N-ethyl-N,N-diisopropylamine In chloroform-d1 at 50℃; for 3h; Inert atmosphere;
4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

4-methylvaleroyl chloride
38136-29-7

4-methylvaleroyl chloride

(4R,5S)-4-methyl-3-(4-methylpentanoyl)-5-phenyl-oxazolidin-2-one
134458-52-9

(4R,5S)-4-methyl-3-(4-methylpentanoyl)-5-phenyl-oxazolidin-2-one

Conditions
ConditionsYield
Stage #1: 4-methyl-5-phenyloxazolidin-2-one With n-butyllithium In tetrahydrofuran; hexane at -78 - 0℃; for 0.25h; Inert atmosphere;
Stage #2: 4-methylvaleroyl chloride In tetrahydrofuran; hexane at -78℃; for 0.5h; Inert atmosphere;
97%
With n-butyllithium; sodium hydrogencarbonate In tetrahydrofuran; hexanes at -78 - 0℃; for 1.41667h; Argon atmosphere;82%
Stage #1: 4-methyl-5-phenyloxazolidin-2-one With n-butyllithium In tetrahydrofuran; hexane at -78℃; for 0.166667h;
Stage #2: 4-methylvaleroyl chloride In tetrahydrofuran; hexane at -78℃; for 0.5h;
38%
4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

3-(4,4-dimethyl-heptanoyl)-(R)-4-methyl-(S)-5-phenyl-oxazolidin-2-one
610300-44-2

3-(4,4-dimethyl-heptanoyl)-(R)-4-methyl-(S)-5-phenyl-oxazolidin-2-one

Conditions
ConditionsYield
Stage #1: 4,4-dimethyl-heptanoic acid With pivaloyl chloride; triethylamine In tetrahydrofuran at 0℃; for 1h;
Stage #2: 4-methyl-5-phenyloxazolidin-2-one With lithium chloride In tetrahydrofuran for 18h;
95%
4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

4,4-dimethyl-heptanoic acid
50902-80-2

4,4-dimethyl-heptanoic acid

3-(4,4-dimethyl-heptanoyl)-(R)-4-methyl-(S)-5-phenyl-oxazolidin-2-one
610300-44-2

3-(4,4-dimethyl-heptanoyl)-(R)-4-methyl-(S)-5-phenyl-oxazolidin-2-one

Conditions
ConditionsYield
Stage #1: 4,4-dimethyl-heptanoic acid With pivaloyl chloride; triethylamine In tetrahydrofuran for 1h;
Stage #2: 4-methyl-5-phenyloxazolidin-2-one With lithium chloride In tetrahydrofuran for 18h;
95%
4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

3-cyano-4,6-dimethyl-2-pyridinyl tosylate
1174281-26-5

3-cyano-4,6-dimethyl-2-pyridinyl tosylate

4,6-dimethyl-2-((4R,5S)-4-methyl-2-oxo-5-phenyloxazolidin-3-yl)nicotinonitrile
1233503-31-5

4,6-dimethyl-2-((4R,5S)-4-methyl-2-oxo-5-phenyloxazolidin-3-yl)nicotinonitrile

Conditions
ConditionsYield
With 1,1'-bis-(diphenylphosphino)ferrocene; potassium carbonate; bis(dibenzylideneacetone)-palladium(0) In 1,4-dioxane at 100℃; for 16h; Inert atmosphere;95%
4-(2-propenyloxy)butanoyl chloride
922724-77-4

4-(2-propenyloxy)butanoyl chloride

4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

(4R)-methyl-(5S)-phenyl-3-(4-propenyloxy)butanoyloxazolidin-2-one
922724-76-3

(4R)-methyl-(5S)-phenyl-3-(4-propenyloxy)butanoyloxazolidin-2-one

Conditions
ConditionsYield
With n-butyllithium In tetrahydrofuran for 0.5h; cooling;94%
4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

trans-chrotonyl chloride
625-35-4, 3488-22-0, 10487-71-5

trans-chrotonyl chloride

(4R,5S)-3-((E)-2-butenoyl)-4-methyl-5-phenyl-2-oxazolidinone
90719-31-6

(4R,5S)-3-((E)-2-butenoyl)-4-methyl-5-phenyl-2-oxazolidinone

Conditions
ConditionsYield
With n-butyllithium 1.) THF, -78 deg C, 15 min; 2.) THF, -78 deg C, 30 min then 0 deg C, 15 min;93%
Stage #1: 4-methyl-5-phenyloxazolidin-2-one With n-butyllithium In tetrahydrofuran at -40℃;
Stage #2: trans-chrotonyl chloride In tetrahydrofuran at -50℃; Further stages.;
4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

(methylthio)acetyl chloride
35928-65-5

(methylthio)acetyl chloride

(4R,5S)-3-(1'-oxo-2'-methylthioethyl)-4-methyl-5-phenyl-2-oxazolidinone
116857-38-6

(4R,5S)-3-(1'-oxo-2'-methylthioethyl)-4-methyl-5-phenyl-2-oxazolidinone

Conditions
ConditionsYield
With n-butyllithium In tetrahydrofuran 1.) -78 deg C, 30 min, 2.) r.t., 30 min;93%
77%
4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

acetic anhydride
108-24-7

acetic anhydride

(4R,5S)-3-acetyl-4-methyl-5-phenyl-2-oxazolidinone
96093-41-3

(4R,5S)-3-acetyl-4-methyl-5-phenyl-2-oxazolidinone

Conditions
ConditionsYield
Stage #1: 4-methyl-5-phenyloxazolidin-2-one With tetraethylammonium perchlorate In acetonitrile at 20℃; Electrochemical reaction;
Stage #2: acetic anhydride With tetraethylammonium perchlorate In acetonitrile at 20℃; for 3h; Further stages.;
93%
4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

4-triethylsilyloxy-4-methylpentanoic acid
383397-31-7

4-triethylsilyloxy-4-methylpentanoic acid

(4R,5S)-(+)-4-methyl-5-phenyl-3-[4-triethylsilyloxy-4-methylpentanoyl]-2-oxazolidinone
383397-33-9

(4R,5S)-(+)-4-methyl-5-phenyl-3-[4-triethylsilyloxy-4-methylpentanoyl]-2-oxazolidinone

Conditions
ConditionsYield
With dmap; pivaloyl chloride; triethylamine93%
4-methyl-5-phenyloxazolidin-2-one
77943-39-6

4-methyl-5-phenyloxazolidin-2-one

(S)-(-)-citronellic acid
2111-53-7

(S)-(-)-citronellic acid

(4R,5S)-3-(3,7-dimethyloct-6-enoyl)-4-methyl-5-phenyl-2-oxazolidinone
954106-37-7

(4R,5S)-3-(3,7-dimethyloct-6-enoyl)-4-methyl-5-phenyl-2-oxazolidinone

Conditions
ConditionsYield
With dmap; pivaloyl chloride; triethylamine In tetrahydrofuran for 24h; Heating;93%

77943-39-6Relevant articles and documents

Asymmetric ammonium ylid rearrangements: the effect of nitrogen asymmetry

Sweeney,Tavassoli, Ali,Workman, James A.

, p. 11506 - 11512 (2006)

[2,3]-Sigmatropic rearrangements of allylic ammonium ylids derived from glycinoylcamphorsultams are highly selective in terms of relative and absolute stereocontrol only when acyclic alkenes are present. When chiral esters of ylids derived from N-methyltetrahydropyridine ('NMTP') undergo rearrangement, the reactions show exclusive cis-stereoselectivity but the products are obtained with virtually no absolute stereocontrol. These observations support the notion that sigmatropic rearrangements of N-chiral ammonium ylids are controlled by nitrogen stereogenicity.

Stereoselective synthesis of oxazolidin-2-ones via an asymmetric aldol/curtius reaction: Concise total synthesis of (?)-cytoxazone

Choi, Hosam,Choi, Joohee,Jang, Hanho,Lee, Kiyoun

, (2021/06/14)

Herein, we are reporting an efficient approach toward the synthesis of 4,5-disubstituted oxazolidin-2-one scaffolds. The developed approach is based on a combination of an asymmetric aldol and a modified Curtius protocol, which uses an effective intramolecular ring closure to rapidly access a range of oxazolidin-2-one building blocks. This strategy also permits a straightforward and concise asymmetric total synthesis of (?)-cytoxazone. Consisting of three steps, this is one of the shortest syntheses reported to date. Ultimately, this convenient platform would provide a promising method for the early phases of drug discovery.

Tandem copper and photoredox catalysis in photocatalytic alkene difunctionalization reactions

Reed, Nicholas L.,Herman, Madeline I.,Miltchev, Vladimir P.,Yoon, Tehshik P.

supporting information, p. 351 - 356 (2019/02/20)

Oxidative alkene difunctionalization reactions are important in synthetic organic chemistry because they can install polar functional groups onto simple non-polar alkene moieties. Many of the most common methods for these reactions rely upon the reactivity of pre-oxidized electrophilic heteroatom donors that can often be unstable, explosive, or difficult to handle. Herein, we describe a method for alkene oxyamination and diamination that utilizes simple carbamate and urea groups as nucleophilic heteroatom donors. This method uses a tandem copper–photoredox catalyst system that is operationally convenient. The identity of the terminal oxidant is critical in these studies. Ag(I) salts proved to be unique in their ability to turn over the copper cocatalyst without deleteriously impacting the reactivity of the organoradical intermediates.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 77943-39-6